Sorry, this entry is only available in Ukrainian.
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
Pharmaceutical company “Darnytsia” together with the Ukrainian Pharmaceutical Students’ Association (UPSA) are preparing a series of podcasts about pharmaceutics. Company experts will tell students about clinical trials, registration, production, logistics,…